Related Experiment Videos
[Hepatocyte growth factor (HGF) and atherosclerosis]
Waldemar Kazberuk1, Michał Myśliwiec, Bogdan Galar
1Klinika Nefrologii i Transplantologii wraz z Ośrodkiem Dizaliz AM w Białymstoku. walkaz@poczta.fm
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|November 24, 2004
Summary
Hepatocyte growth factor (HGF) aids tissue repair and has proven therapeutic potential for cardiovascular diseases like atherosclerosis. Its concentration predicts cardiovascular event risk and is influenced by medications.
Area of Science:
- Molecular biology
- Cardiovascular research
- Regenerative medicine
Context:
- Hepatocyte growth factor (HGF) is crucial for tissue regeneration and survival after injury.
- HGF exhibits potent cell growth, anti-apoptotic, migration, and differentiation regulatory functions.
- Investigational applications for HGF include gene therapy for conditions like angina pectoris and intermittent claudication.
Purpose:
- To review the role of HGF in the pathogenesis and treatment of atherosclerosis.
- To discuss the angiogenic activity of HGF.
- To explore the clinical significance of HGF plasma concentration in cardiovascular risk assessment.
Summary:
- HGF demonstrates significant angiogenic activity both in vivo and in vitro.
- Elevated HGF plasma levels are observed in patients with arterial collaterals.
- HGF concentration can predict the likelihood of cardiovascular events.
- Plasma HGF levels increase substantially after heparin administration, especially unfractionated heparin.
- ACE-inhibitors may also influence HGF synthesis.
Impact:
- HGF's role in atherosclerosis pathogenesis and treatment is a key area of research.
- Understanding HGF regulation by drugs like heparin and ACE-inhibitors can inform therapeutic strategies.
- HGF plasma concentration serves as a potential biomarker for cardiovascular risk stratification.